Stanford University
Showing 22,141-22,160 of 36,330 Results
-
Mete Muslu
Postdoctoral Scholar, Electrical Engineering
BioA. Mete Muslu received his B.Sc. and M.Sc. degrees in Mechanical Engineering from Ozyegin University, Istanbul, Turkey, in 2018 and 2020, respectively, and his Ph.D. in Mechanical Engineering from the Georgia Institute of Technology, Atlanta, GA, USA, in 2025. His doctoral research focused on developing single- and two-phase cooling solutions for integrated power electronics packages and multi-functional cold plates. His current research interests include understanding device-level multi-physics and developing integrated thermal management solutions spanning from the chip to the package level for high-performance computing and power applications.
-
Maggie Mustaklem
Overseas Studies - Oxford, Bing Overseas Studies
BioMaggie Mustaklem is a PhD student at the University of Oxford focusing on AI and creativity. Her doctoral research project, Who and What is Designing Design, centers on algorithmic image search and the images creative professionals use for inspiration. Maggie holds a Master of Arts in History of Design from the Royal College of Art and Victoria & Albert Museum and a Bachelor of Arts in Psychology from the University of Michigan.
In addition to her research, Maggie is the project lead on AI Yesterday, a digital zine and multimedia forum that critically engages with AI histories, challenging dominant narratives about AI’s potential futures. Through experimental, freeform participation, AI Yesterday embraces voices and outputs that academic writing and journalism often exclude. -
Adel Mutahar
Postdoctoral Scholar, General and Vascular Surgery
BioDr. Adel Z. I. Mutahar is a postdoctoral researcher in the Department of Surgery at Stanford University, working under the mentorship of Dr. Frederick M. Dirbas. His research focuses on translational breast cancer biology and emerging radiotherapy technologies, with an emphasis on tumor–microenvironment interactions, immuno-oncology, and preclinical therapeutic development. His academic journey spans three countries—beginning in Yemen, advancing through India, and now progressing at Stanford—reflecting his commitment to impactful cancer research and global scientific advancement.
Dr. Mutahar began his career in Yemen, earning his Bachelor’s degree in Medical Laboratory Sciences before joining Abs Community College as a faculty member. From 2007–2013, he held several academic leadership roles, including Academic Director, Head of Evaluation, and Assistant Dean of Students, where he modernized curriculum, expanded hands-on diagnostic training, and strengthened laboratory education infrastructure in resource-limited settings. His work contributed to building a more skilled medical diagnostics workforce and improving pathways for laboratory science education.
Awarded a prestigious national merit scholarship, Dr. Mutahar continued his graduate and doctoral training in India, completing his M.S. and Ph.D. in Biotechnology with a focus on triple-negative breast cancer. During his doctoral work, he developed 3D tumor spheroid models and combinatorial therapeutic strategies, demonstrating synergy between anti-angiogenic agents and chemotherapy in TNBC. He further advanced this research by creating an orthotopic murine model to investigate metastatic progression and demonstrated that knockdown of the MTA1 gene in mesenchymal stem cells (MSCs) significantly suppressed TNBC invasion, angiogenesis, and metastatic spread, introducing a promising stromal-targeted therapeutic concept for aggressive breast cancer. This work earned recognition through travel grants, conference presentations, and a Best Poster Award. His scientific adaptability was further demonstrated during the COVID-19 pandemic, when he uncovered a novel interaction between SARS-CoV-2 Spike RBD and VEGF signaling.
At Stanford, his work emphases on FLASH radiotherapy, an ultrahigh-dose-rate modality with the potential to widen the therapeutic window by minimizing normal-tissue toxicity while maintaining tumor control. Working within Dr. Dirbas’s translational breast oncology program, Dr. Mutahar employs patient-derived xenografts, orthotopic murine models, spatial transcriptomics, single-cell RNA sequencing, and immune profiling to dissect the biological mechanisms governing treatment response. His research integrates multi-omics analysis to map early and late radiotherapy injury pathways—including senescence, apoptosis and fibrosis. His goal is to develop mechanism-driven radio-immunotherapy strategies and durable FLASH-RT combination regimens that can be translated into clinical trials for breast cancer, improving therapeutic durability, minimizing toxicity, and ultimately enhancing patient outcomes.
Dr. Mutahar’s long-term vision is to establish an independent laboratory at the intersection of radiobiology, immuno-oncology, and translational therapeutics. Guided by Dr. Dirbas’s mentorship and shaped by multidisciplinary experience across three continents, he aims to develop biologically informed treatment strategies that eradicate tumors while preserving normal tissue and immune integrity—ultimately improving quality of life and survival for women with aggressive breast cancers. -
Gabriella Muwanga
Temp - Non-Exempt, Anesthesia - Adult Pain Medicine
BioGabriella Muwanga is a Neurosciences graduate student in the Tawfik and Airan labs at Stanford. She is interested in understanding acute and chronic pain mechanisms and developing therapies for acute and chronic pain through basic and translational research. Gabriella holds a Bachelor of Science in Biomedical Sciences from Makerere University, Kampala, Uganda. She is passionate about teaching, mentorship, science communication, and fostering diversity in science. Outside the lab, she enjoys writing, singing, drawing, Bible Study, and fellowship.
-
Hafsah Muzaffer
Affiliate, Stanford Online High School
BioFull-time junior at Stanford Online High School with interests in cognitive science, math, CS and philosophy.
